Table 4.
Bivariate Analyses Baseline v. Follow-up Perceptions by Study Arm
| HPV Arm | Control Arm | |||||
|---|---|---|---|---|---|---|
| Baseline (n=136) | Follow-up (n=126) | Baseline (n=142) | Follow-up (n=133) | p1 | p2 | |
| Perceived risk of cervical cancer (mother) | ||||||
| % Yes | 22.8 | 44.8 | 11.4 | 23.9 | ||
| % No | 22.1 | 16.2 | 22.9 | 32.4 | 0.038 | <0.001 |
| % DK/NS | 55.1 | 39.0 | 65.7 | 43.7 | ||
| Perceived risk of HPV infection (mother) | ||||||
| % Yes | 10.3 | 25.0 | 5.7 | 3.5 | ||
| % No | 59.6 | 43.4 | 49.3 | 59.3 | 0.027 | <0.001 |
| % DK/NS | 30.1 | 31.6 | 45.0 | 47.2 | ||
| Perceived risk of daughter’s future HPV infection | ||||||
| % Yes | 59.6 | 71.3 | 40.1 | 52.1 | ||
| % No | 9.6 | 11.8 | 4.2 | 2.8 | <0.001 | <0.001 |
| % DK/NS | 30.9 | 16.9 | 55.6 | 45.1 | ||
| Worry about future HPV infection (mother) | ||||||
| % Yes | 68.4 | 77.2 | 62.4 | 59.9 | ||
| % No | 22.8 | 16.2 | 17.7 | 24.6 | 0.029 | 0.005 |
| % DK/NS | 8.8 | 6.6 | 19.9 | 15.5 | ||
| Worry about daughter’s future HPV infection | ||||||
| % Yes | 83.1 | 89.7 | 82.4 | 81.7 | 0.288 | <0.001 |
| % No | 5.1 | 6.6 | 2.1 | 1.4 | ||
| % DK/NS | 11.8 | 3.7 | 15.5 | 16.9 | ||
| Completed 1st dose of HPV vaccine (daughter) | ||||||
| % Yes | - | 52.2 | - | 15.5 | - | <0.001 |
| % No | - | 47.8 | - | 84.5 | ||
| Completed 2nd dose of HPV vaccine (daughter) | ||||||
| % Yes | - | 40.4 | - | 7.8 | - | <0.001 |
| % No | - | 59.6 | - | 92.2 | ||
| Completed 3rd dose of HPV vaccine (daughter) | ||||||
| % Yes | - | 32.3 | - | 2.8 | - | <0.001 |
| % No | - | 67.7 | - | 97.2 | ||
DK/NS=Don’t know/Not sure; HPV=human papillomavirus
1
p-value between arms at baseline
2
p-value between arms at 7-month follow-up